Edward joined us as a partner in June, 2021. He came to Sofinnova Partners from M Ventures, Merck KGaA’s corporate VC arm, where he focused on investments in cutting-edge digital medicine companies, including Akili Interactive Labs, maker of the first FDA-approved prescription videogame.
Before that, Edward was in the Life Sciences securities team at Kempen & Co, a pan-European merchant bank, covering listed small- and mid-cap life sciences equities. He started his career as an analyst within the biopharma investment team of M Ventures.
Edward is positive, energetic and purpose-driven — and he enjoys a challenge. In 2012, for instance, he took on the Gobi desert in an underpowered 1.2L Chevrolet Aveo, which he and his team drove from London to Mongolia to raise money for SOS Children's Villages.
He holds an M.Sc. in Biopharmaceutical Sciences from Leiden University, the Netherlands, with a specialization in pharmacology.